1nhaler secures £2.2 million to continue late-stage development
The 1nhaler, a Scotland-based drug delivery device developer, has secured £2.2 million in follow-on funding to progress its…
Doctor warns item could be ‘most toxic in your home’ without you even realising
Naturopathic doctor Pedi Mirdamadi says the everyday item may contain toxic chemicals – including formaldehyde – that could…
Common asthma drug improves strength in children with muscle disease
A common asthma medication improves motor skills and muscle strength in children with congenital myopathies, a group of…
Pharmacist’s ‘serious red flag’ warning to asthma patients using a blue inhaler this winter
Blue inhalers have been a staple for millions of people with asthma for decades – but new NICE…
European Commission approves new treatment for severe asthma
Exdensur (depemokimab) is the first and only ultra-long-acting biologic in the EU to treat severe asthma and chronic…
Asthma Adviceline reduces ED and out-of-hours visits
A new way for clinicians to refer people with asthma for advice and support aims to provide benefits…
Call for more investment in lung health as part of Budget 2027
Respiratory organisations mark World Lung Day with call for action in next month’s Budget announcement Increased investment in…
Weight loss drugs could help with asthma and COPD
Semaglutide-based drugs have quickly become established as treatments for obesity and diabetes, even as signs have emerged that…
Tirzepatide vs semaglutide for asthma: the difference was smaller than researchers expected
Researchers compared two widely used incretin therapies in more than 16,000 matched adults with asthma and type 2…
City in Lehigh Valley ranked as most challenging place to live with asthma in continental US | Allentown Area
ALLENTOWN, Pa. – A report has ranked Allentown as the #1 most challenging city to live with asthma.…
TGA approves new severe asthma treatment Exdensur for Australians
A newly registered asthma treatment has been given the green light by the Therapeutic Goods of Australia (TGA),…
Study questions antihistamine use for managing eczema symptoms
Adding oral antihistamines to existing eczema treatments is unlikely to lead to clinically important reductions in eczema and itch…